Recurrent anal abscess and cecal perforation as a first presentation of Behcȩt's disease;Abcès para-anaux récidivants et perforation cæcale révélant une maladie de Bençet

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 10, 2003, Pages 940-943

  Haller, Claude ^a,b   Guenot, Cécile ^a   Ödman, Micaela ^a   Bruttin, Jean Marie ^a   Rosso, Raphaël ^a  

^a Hopital de Morges   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; ADULT; ANAL ABSCESS; ARTICLE; BEHCET DISEASE; CASE REPORT; CECUM PERFORATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTESTINE PERFORATION; RECURRENT DISEASE;

ABSCESS; ADULT; ANUS DISEASES; BEHCET SYNDROME; CECAL DISEASES; FEMALE; HUMANS; INTESTINAL PERFORATION; RECURRENCE;

EID: 0242299076     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
2. Kaklamani VG, Variopoulos G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998;27:197-217
3. Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behçet's Disease: Review of 136 Surgical Cases in the Japanese Literature. Dis Colon Rectum 1981;24:103-6
4. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997;38:411-22
5. Nakae K, Maski F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet's disease in Japan. In: Wechsler B, Godeau P, eds. Behçet's disease. Amsterdam: Excerpta Medica, 1993:145-51
6. Yurdakul S, Gunaydin I, Tuzun Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988;15:820-2
7. Tuzun Y, Yurdakul S, Cem Mat M, Ozyazgan Y, Hamuryudan V, Tuzun B, et al. Epidemiology of Behçet's syndrome in Turkey. Int J Dermatol 1996;35:618-20
8. Tsukada S, Yamazaki T, Iyo S, Nishio I, Hashimoto K, Matsubara F. Neuro-Behçet's syndrome: report of two cases and review of the literature. Saishin-Igaku 1964;19:1533-41
9. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behçet's disease. J Clin Gastroenterol 2000;30:144-54
10. Kodoma H. Intestinal Behçet's. Surg Ther 197;37:51-8
11. Hamza M, Eleuch M, Kchir N, Zitouna M. Ileal perforation in 3 cases of Behcet disease. Ann Med Interne (Paris) 1994;145:99-102
12. Tsukada S, Yamazaki T, Iyo S, Nishio I, Hashimoto K, Matsubara F. Neuro-Behçet's syndrome: report of two cases and review of the literature. Saishin-Igaku 1964;19:1533-41
13. Roge J. Behçet's syndrome and the digestive tract. J Mal Vasc 1988;13:235-9
14. Nakano H, Takano E, Kondoh H. Behçet's disease with multiple large ulcer in the right colon, report of a case. Stomach Intestine 1992;27:327-32
15. Parkin JV, Wight DG. Behçet's disease and alimentary tract. Postgrad Med J 1975;51:260-4
16. Lockhart JM, McIntyre W, Caperton EM Jr. Esophageal ulceration in Behçet's syndrome (letter). Ann Intern Med 1976;84:572-3
17. Kim JH, Choi BI, Han JK, Choo SW, Han MC. Colitis in Behcet's disease: characteristics on double-contrast barium enema examination in 20 malades. Abdom Imaging 1994;19:132-6
18. Baba S, Maruta M, Ando K, Tatsuo T, Endo I. Intestinal Behçet's disease: report of five cases. Dis Colon Rectum 1976;19:428-40
19. Mansi Ia, Opran A, Rosner F. ANCA-associated small-vessel vasculitis. Am Fam Physician 2002;65:1615-20
20. Ben Hmida M, Hachicha J, Kaddour N, Makni H, Aydel FZ, Chakroun N, et al. ANCA in Behçet's disease. Nephrol Dial Transplant 1997;12:2465-6
21. Mattioli F, Capra R, Rovaris M, Chiari S, Codella M, Miozzo A, et al. Frequency and patterns of subclinical cognitive impairment in malades with ANCA-associated small vessel vasculitides. J Neurol Sci 2002;195:161-6
22. Savige J, Davies D, Falk RJ, Jennette JC, Wilk A. Antineutrophil cytoplasmic antibodies and associated diseases: A rview of the clinical and laboratory fearures. Kidney International 2000;57:846-62
23. Gal AA, Velasquez A. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist. Mod Pathol 2002;15:197-204
24. Zouboulis CC, Buttner P, Djawari D, Kirch W, Keitel W, Garbe C, et al. The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 malades. Hautarzt 1993;44:81-5
25. Sakane T. New perspective on Behçet's disease. Int RevImmunol 1997;14:89-96
26. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91
27. Pirildar T, Keser G, Tune E, Alkanat M, Tuncyurek M, Doganavasargil E. An unusuel presentation of Behçet's Disease: intestinal perforation. Clin Rheumatol 2001;20:61-2
28. Önder M, Gürer MA. Behçet's disease: an enigmatic vasculitis. Clin Dermatol 1999;17:571-6
29. Miyachi Y, Taniguchi S, Ozaki M, Horio T. Colchicine in the treatment of cutaneous manifestations of Behçet's disease. Br J Dermatol 1981;104:67-9
30. Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, et al. Azathioprine in Behçet's syndrome: effets on long-term prognosis. Arthritis Rheum 1997;40:769-74
31. Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5
32. O'Duffy JD, Robertson MD, Goldstein NP. Chlorambucil in the treatment of uveitis and meningoencephaliktis of Behçet's disease. Am J Med 1984;76:75-84
33. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1989;1:1093-6
34. Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system synptoms in malades with Behçet disease receiving cyclosporine therapy. Ophthalmology 1999;106:586-9
35. Kazokoglu H, Saatci O, Cuhadaroglu H, Eldem B. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease. Ann Ophthalmol 1991;23:148-51
36. Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch Dermatol 1998;134:1010-6
37. O'Duffy JD, Calamia K, Cohen S, Goronzy JJ, Haerman D, Jorizzo J, et al. Interferon-alpha treatment of Behçet's disease. J Rheumatol 1998;25:1938-44
38. Yasui K, Otha K, Kobayashi M, Aizawa T, Komiyama A. Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med 1996;124:891-3
39. Shek LP, Lee YS, Lee BW, Lehman TJ. Thalidomide responsiveness in an infant with Behçet's syndrome. Pediatrics 1999;103:1295-7
40. Gardner-Medwin JMM, Smith NJ, Powell RJ. Clinical experience with thalidomide in the management of sever oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994;53:828-32
41. Jorizzo JL, Schmalstieg FC, Solomon AR Jr, Cavallo T, Taylor RS 3rd, Rudloff HB, et al. Thalidomide effects in Behçet's syndrome and pustular vasculitis. Arch Intern Med 1996;146:878-81
42. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A. Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:443-50
43. Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumos necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report. Gastroenterology 2001;120:995-9.
44. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 2001;49:725-8.
45. Kume K, Hashiba T, Yoshikawa I, Kanda K, Narita R, Otsuki M. Therapeutic experience of hyperbaric oxygenation in entero-Bahcet syndrome. Am J Gastroenterol 2001;96:1308-9.
46. Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WS, Chi HS. Surgical treatment of intestinal Behcet's disease. Yonsei Med J 1997;38:455-60.
47. Baba S, Kamitani T. Behcet's disease. J Clin Surg 1979;34:863-7.
48. Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, et al. Analysis of clinical course and long term prognosis of surgical and nonsurgical patients with intestinal Bahcet's disease. Am J Gastroenterol 200;95:2848-51.
49. Griffin JW, Harrison HB, Tedesco FJ, Mills LR. Behcet's disease with multiple sites of gastrointestinal involvement. South Med J 1982;75:1405-8.
50. Roge J. Intestinal involvement in Behcet's syndrome. Presse Med 1985;14:537-41.
51. Jung HC, Rhee PL, Song IS, Choi KW, Kim CY. Temporal changes in the clinical type or diagnosis of Behcet's colitis in patients with aphthoid or punched-out colonic ulcerations. J Korean Med Sci 1991;6:313-8.